New Delhi, October 27, 2025 – Nicolab, a global leader in AI-powered stroke care, and Philips are proud to announce the launch of StrokeViewer in India. This milestone marks a significant step forward in improving stroke treatment workflows across the country, ensuring that more patients receive timely and effective care.
With nearly 1.8 million new cases each year*, stroke has become a leading cause of disability and mortality in India, creating an urgent need for models of care that deliver speed, precision and access. Timely diagnosis and intervention are critical, yet many patients continue to face delays in accessing specialist treatment. Through this collaboration, Philips and Nicolab aim to strengthen clinical workflows, support faster decision-making and improve access to life-saving
stroke treatment.
StrokeViewer, the first cloud-based solution in India to receive regulatory clearance for CT Perfusion (CTP) analysis provides instant AI-generated imaging results, centralised patient information and seamless communication between specialists. Integrated with Philips’ advanced Azurion imaging technology, the combined solution is designed to help clinicians deliver more efficient and effective stroke care.
Gaurav Vyas, Business Leader, Image Guided Therapy, Philips Indian Subcontinent, said, “Stroke is a growing healthcare challenge in India, where every minute makes a difference to patient outcomes. At Philips, we are committed to harnessing the power of technology and partnerships to improve access, efficiency and quality of care. By joining hands with Nicolab, we are advancing stroke care in India with a connected, AI-driven solution that empowers clinicians to act faster, deliver more effective outcomes, and extend timely treatment to patients even in underserved communities and Tier 2 and 3 cities, ultimately providing better care for more people.”
Michael Macilquham, Nicolab CEO, added: “At Nicolab, our purpose has always been to ensure every stroke patient, regardless of where they live, has the best possible chance of recovery. India presents both an enormous challenge and a profound opportunity. The scale of the stroke burden is immense, yet so is the determination of its clinical community to advance care. Partnering with Philips allows us to support this ambition through proven, AI-powered workflows that connect hospitals, empower clinicians and shorten the time between diagnosis and treatment. Our collaboration is about building capacity, strengthening networks and ensuring that innovation reaches every patient who can benefit from it”.
Nicolab delivers a seamless solution that enhances every step of the stroke care pathway—from imaging to treatment—helping physicians make faster, life-saving decisions. This collaboration highlights the strengths of both companies and our shared commitment to improving outcomes for stroke patients.
Nicolab’s StrokeViewer offers advanced AI technology, implementation expertise, ongoing clinical support, and seamless workflow integration to drive real-world clinical transformation. StrokeViewer enables physicians to view, analyze and track cases from multiple sites in one location, ensuring streamlined collaboration and enhanced stroke care coordination.
About Nicolab
Nicolab, established in 2015 following the world-leading MR CLEAN clinical trial, is an Australian-based public unlisted company. Comprised of a team of esteemed researchers, developers, and medical specialists, Nicolab is dedicated to developing innovative healthcare solutions that improve patient care. Operating globally, Nicolab’s flagship product, StrokeViewer, enables clinicians to connect, communicate, and collaborate effectively within their stroke network, revolutionizing stroke workflow and treatment planning. Learn more www.nicolab.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
For further information, please contact:
Nicolab
Honey Singh
hsingh@nicolab.com
Philips
Gunjan Mukherjee
gunjan.mukherjee@philips.com